购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-54(Compound 158)作为一款羟基类固醇17β-脱氢酶13(HSD17B13)抑制剂,展示了对雌二醇的高效抑制能力,其IC50值达到或低于0.1 μM。此化合物主要应用于研究肝病、代谢性疾病及心血管疾病,例如非酒精性脂肪肝病(NAFLD)、非酒精性脂肪肝炎(NASH)及药物性肝损伤(DILI)。
HSD17B13-IN-54(Compound 158)作为一款羟基类固醇17β-脱氢酶13(HSD17B13)抑制剂,展示了对雌二醇的高效抑制能力,其IC50值达到或低于0.1 μM。此化合物主要应用于研究肝病、代谢性疾病及心血管疾病,例如非酒精性脂肪肝病(NAFLD)、非酒精性脂肪肝炎(NASH)及药物性肝损伤(DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-54 (Compound 158) functions as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 value of ≤ 0.1 μM against estradiol. This compound holds potential for applications in the study of various liver, metabolic, and cardiovascular diseases, including NAFLD and NASH, as well as drug-induced liver injury (DILI) [1]. |
分子量 | 540.29 |
分子式 | C24H15Cl2F4N3O3 |
CAS No. | 2770247-49-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容